JP2014503533A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503533A5
JP2014503533A5 JP2013544685A JP2013544685A JP2014503533A5 JP 2014503533 A5 JP2014503533 A5 JP 2014503533A5 JP 2013544685 A JP2013544685 A JP 2013544685A JP 2013544685 A JP2013544685 A JP 2013544685A JP 2014503533 A5 JP2014503533 A5 JP 2014503533A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
inflammation
compound
dermatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013544685A
Other languages
English (en)
Japanese (ja)
Other versions
JP5932830B2 (ja
JP2014503533A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/064590 external-priority patent/WO2012082718A2/en
Publication of JP2014503533A publication Critical patent/JP2014503533A/ja
Publication of JP2014503533A5 publication Critical patent/JP2014503533A5/ja
Application granted granted Critical
Publication of JP5932830B2 publication Critical patent/JP5932830B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013544685A 2010-12-15 2011-12-13 炎症及び疼痛を処置するための3‐メタンスルホニルプロピオニトリル Active JP5932830B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42348510P 2010-12-15 2010-12-15
US61/423,485 2010-12-15
PCT/US2011/064590 WO2012082718A2 (en) 2010-12-15 2011-12-13 3-methanesulfonylpropionitrile for treating inflammation and pain

Publications (3)

Publication Number Publication Date
JP2014503533A JP2014503533A (ja) 2014-02-13
JP2014503533A5 true JP2014503533A5 (cg-RX-API-DMAC10.html) 2015-01-08
JP5932830B2 JP5932830B2 (ja) 2016-06-08

Family

ID=46235178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013544685A Active JP5932830B2 (ja) 2010-12-15 2011-12-13 炎症及び疼痛を処置するための3‐メタンスルホニルプロピオニトリル

Country Status (11)

Country Link
US (8) US8476316B2 (cg-RX-API-DMAC10.html)
EP (1) EP2651407B1 (cg-RX-API-DMAC10.html)
JP (1) JP5932830B2 (cg-RX-API-DMAC10.html)
KR (1) KR101849813B1 (cg-RX-API-DMAC10.html)
CN (1) CN103260613B (cg-RX-API-DMAC10.html)
AU (1) AU2011344030B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013014583A2 (cg-RX-API-DMAC10.html)
CA (1) CA2820625C (cg-RX-API-DMAC10.html)
MX (1) MX2013006708A (cg-RX-API-DMAC10.html)
TW (1) TWI522338B (cg-RX-API-DMAC10.html)
WO (1) WO2012082718A2 (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102002664B1 (ko) 2012-02-27 2019-07-23 오라텍 세라퓨틱스 엘엘씨 3-메틸술포닐프로피오니트릴의 제조 방법
AU2013271778B2 (en) * 2012-06-05 2018-03-01 Olatec Therapeutics Llc Pharmaceutical composition for treating inflammation and pain
US9481644B2 (en) 2012-06-05 2016-11-01 Olatec Therapeutics Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
JP6185575B2 (ja) 2012-06-05 2017-08-23 オラテック セラピューティクス リミティド ライアビリティ カンパニー 皮膚炎症性疾患の治療方法
CA2875053C (en) * 2012-06-05 2020-07-14 Olatec Industries Llc Pharmaceutical composition for treating inflammation and pain
MX368641B (es) 2012-06-11 2019-10-09 Olatec Ind Llc Compuestos para el tratamiento de inflamación y dolor.
US9114122B2 (en) 2012-06-14 2015-08-25 Olatec Industries Llc Compounds for treating inflammation and pain
WO2013188314A1 (en) * 2012-06-14 2013-12-19 Olatec Industries Llc Compounds for treating inflammation and pain
SI3021873T1 (sl) * 2013-07-18 2018-12-31 Xalud Therapeutics, Inc. Sestavek za zdravljenje vnetne sklepne bolezni
WO2015026851A1 (en) 2013-08-20 2015-02-26 Olatec Industries Llc Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate
WO2015048328A1 (en) * 2013-09-26 2015-04-02 Olatec Industries Llc 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use
US9440916B2 (en) 2013-09-26 2016-09-13 Olatec Therapeutics Llc 3, 4-bis-benzylsulfonylbutyronitrile and its pharmaceutical use
WO2015050878A1 (en) * 2013-10-01 2015-04-09 Olatec Industries Llc Pharmaceutical use of 3-benzylsulfonylpropionitrile
US9999610B2 (en) 2013-10-01 2018-06-19 Olatec Therapeutics Llc Pharmaceutical use of 3-benzylsulfonylpropionitrile
JP6426746B2 (ja) * 2013-10-07 2018-11-21 オラテック セラピューティクス リミティド ライアビリティ カンパニー 4−メチルスルホニル−2−ブテンニトリル及びその医薬上の使用
US9522878B2 (en) 2013-10-07 2016-12-20 Olatec Therapeutics Llc 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use
WO2015081188A1 (en) * 2013-11-27 2015-06-04 Olatec Industries Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
US9949915B2 (en) 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
ES2970485T3 (es) * 2017-01-06 2024-05-29 Olatec Therapeutics Llc Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares
US10273203B2 (en) 2017-04-11 2019-04-30 Olatec Therapeutics Llc Deuterated 3-methanesulfonylpropionitrile
AU2018313164A1 (en) * 2017-08-11 2020-03-19 Olatec Therapeutics Llc Method for treating Schnitzler's syndrome
WO2019152627A1 (en) * 2018-01-31 2019-08-08 Olatec Therapeutics Llc Method for preventing or treating alzheimer's disease
JP7229565B2 (ja) * 2018-03-21 2023-02-28 オラテック セラピューティクス リミティド ライアビリティ カンパニー メラノーマを治療するための方法
JP7209981B2 (ja) * 2019-05-31 2023-01-23 日本たばこ産業株式会社 触覚刺激に対する幸福感の評価を補助するための方法及び触覚刺激に対する幸福感を評価するためのデータ取得方法
CA3141407A1 (en) * 2019-06-17 2020-12-24 Charles A. Dinarello Method for treating asthma
EP4045009A4 (en) 2019-10-14 2023-11-01 Olatec Therapeutics LLC METHOD FOR TREATING BREAST CANCER
WO2022226495A1 (en) * 2021-04-22 2022-10-27 Olatec Therapeutics Llc Method for treating spinal cord injury
CN118436631B (zh) * 2024-05-08 2025-07-01 中国人民解放军军事科学院军事医学研究院 达泮舒腈在预防和/或治疗急性放射性肺损伤中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3041155A1 (de) * 1980-10-31 1982-06-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,3-dichlor-sulfonyl-acrylnitrilen
JPS58501722A (ja) 1981-10-16 1983-10-13 アボツト ラボラトリ−ズ 〔1↓−(2↓−ベンゾオキサゾリル)ヒドラジノ〕アルキルニトリル誘導体
US5175192A (en) * 1984-03-19 1992-12-29 The Rockefeller University Inhibitors of the advanced glycosylation of proteins and methods of use therefor
EP0355049A3 (en) 1988-08-18 1990-06-13 Zeneca Limited Heterocyclic compounds
US5348838A (en) 1991-07-31 1994-09-20 Kabushiki Kaisha Toshiba Photosensitive composition comprising alkali soluble binder and photoacid generator having sulfonyl group
KR100294084B1 (ko) 1998-06-02 2001-09-22 성재갑 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
KR100288190B1 (ko) 1998-02-09 2001-04-16 김용규 피록시캄 함유 알콜성 하이드로겔 조성물
US6551615B1 (en) * 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
CN1528284A (zh) * 2003-10-06 2004-09-15 南昌弘益科技有限公司 蔊菜素滴丸及其制备方法
US7423064B2 (en) * 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
RU2642628C2 (ru) * 2006-02-16 2018-01-25 Анакор Фармасьютикалз, Инк. Бор-содержащие малые молекулы в качестве противовоспалительных средств
DE602006018367D1 (de) * 2006-03-20 2010-12-30 Olatec Ind Llc Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzen
WO2008101060A1 (en) * 2007-02-14 2008-08-21 Logical Therapeutics, Inc. Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
EP3246034A1 (en) * 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
JP5392261B2 (ja) 2008-08-12 2014-01-22 宇部興産株式会社 非水電解液及びそれを用いたリチウム電池
AU2010226794A1 (en) * 2009-03-18 2011-10-27 Olatec Industries Llc Compounds for treating inflammation and pain

Similar Documents

Publication Publication Date Title
AU2011344030B2 (en) 3-methanesulfonylpropionitrile for treating inflammation and pain
WO2021202720A1 (en) Use of triterpenoid nrf2 inhibitors
JP2013035860A5 (cg-RX-API-DMAC10.html)
SG10201903474PA (en) New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
JPWO2019160057A5 (cg-RX-API-DMAC10.html)
HRP20200394T1 (hr) Smjesa masnih kiselina (gmk, grupa masnih kiselina) za primjenu u liječenju inflamatornih patologija
CN106714792A (zh) 用于治疗炎症性和过敏性病理学的脂肪酸和十六酰胺乙醇的混合物
JP2014527040A5 (cg-RX-API-DMAC10.html)
JP2010515682A5 (cg-RX-API-DMAC10.html)
WO2023036117A1 (zh) L-谷氨酰胺在治疗骨关节炎中的应用
CN107550913A (zh) 4-[9-(6-氨基嘌呤基)]-2(s)-羟基丁酸甲酯在制备治疗银屑病及白癜风药物中的应用
WO2024088153A1 (zh) 托品酸及其衍生物在制备治疗银屑病药物中的用途
CN104095858A (zh) 闭花木酮Cleistanone的O-(哌啶基)乙基衍生物在制备抗慢性阻塞性肺病药物中的应用
JOP20170134A1 (ar) مركبات بينزيميدازول مستبدلة جديدة، عمليات لتحضيرها، مستحضرات صيدلية تشملها واستخدامها لتحضير الأدوية
CN102225896A (zh) 大黄酸的醚衍生物以及它们的治疗用途
CN104116723B (zh) 一类苯衍生物在制备镇痛抗炎药物中的应用
EP3838270B1 (en) Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses
US10273203B2 (en) Deuterated 3-methanesulfonylpropionitrile
RU2014100048A (ru) Соль 4-фенилбитурата, предназначенная для лечения болезни моторных нейронов или метаболического заболевания при ректальном введении
CN103724198A (zh) 富马酸二甲酯的新型衍生物及其应用
BR112020008350A2 (pt) moduladores agonísticos de receptor de glicocorticóide seletivos (segrams) não esteroidais e usos dos mesmos
CN104398525B (zh) 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗慢性阻塞性肺病药物中的应用
CN102283824B (zh) 一种治疗感冒的药物组合物及软胶囊制剂
CN103705437A (zh) 酮洛芬凝胶
WO2019081517A2 (en) NON-STEROIDIC GLUCOCORTICOIC RECEPTOR (SEGRAM) RECEPTOR AGONIST MODULATORS AND USES THEREOF